KA

Kabeer Aziz

Partner at Adjuvant Capital

New York, New York

Overview 

Kabeer Aziz is a Co-founder and Partner at Adjuvant Capital in New York, with a background in investment and finance, having worked at Global Health Investment Fund and Metalmark Capital. He has successfully invested in companies like Minervax, LimmaTech Biologics, and Pulmocide, contributing to the growth of the healthcare and biotech sectors. Aziz's career highlights include his role as a Partner at Adjuvant Capital, where he focuses on investing in various sectors such as diagnostics, medical devices, pharmaceuticals, and biotech, and his previous experience at Global Health Investment Fund, Metalmark Capital, and Greenhill & Co. as an Analyst.

Work Experience 

  • Partner

    2018 - Current

    Leading life sciences investment fund focused on global public health Board of Directors: AN2 Therapeutics, MinervaX, Pulmocide, Quantoom Biosciences, Frontier Nutrition Board Observer: YS Biopharma (2020-2022), Themis (2018-2020)

Adjuvant Capital is a life sciences investment firm focused on global health.

  • Senior Associate

    2015 - 2018

    Impact investing to finance global health research & development

  • Associate

    2013 - 2015

    Private / Growth Equity (Healthcare)

  • Analyst

    2010 - 2013

    Mergers & Acquisitions (Pharma and MedTech)

Greenhill & Co is an investment bank providing financial advices.

Raised $20,000,000.00.

Articles About Kabeer

Relevant Websites